Life Science Connect

Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings

Aug 10, 2026 · 0:50:30

Listen to Episode

✨ AI Summary

Paul Hastings discusses building allogeneic CAR NK cell therapies.
Highlights issues with U.S. clinical trial infrastructure.
Biotech leaders must facilitate patient trial access.

Guests on This Episode

researcher · 1 podcast appearance

More from Life Science Connect

Getting To A First Product Approval With Celcuity's Brian Sullivan

Aug 17, 2026 · 0:50:20

Reimagining Solid Tumor Immunotherapy Through Engineered Tregs with CoRegen's Dr. Sonal Gupta

Aug 13, 2026 · 0:16:22

Fixing AAV Recovery With Siren Biotechnology’s Nathalie Clément, Ph.D.

Aug 12, 2026 · 0:48:16

A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.

Aug 3, 2026 · 0:55:47

View all episodes →